(19)
(11) EP 4 580 615 A1

(12)

(43) Date of publication:
09.07.2025 Bulletin 2025/28

(21) Application number: 23772387.9

(22) Date of filing: 29.08.2023
(51) International Patent Classification (IPC): 
A61K 31/381(2006.01)
A61K 31/137(2006.01)
A61K 31/343(2006.01)
A61P 25/24(2006.01)
A61K 31/135(2006.01)
A61K 31/138(2006.01)
A61K 31/4525(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 31/381; A61P 25/24; A61K 31/343; A61K 31/138; A61K 31/4525; A61K 31/135; A61K 31/137
 
C-Sets:
  1. A61K 31/135, A61K 2300/00;
  2. A61K 31/137, A61K 2300/00;
  3. A61K 31/381, A61K 2300/00;
  4. A61K 31/343, A61K 2300/00;
  5. A61K 31/138, A61K 2300/00;
  6. A61K 31/4525, A61K 2300/00;

(86) International application number:
PCT/US2023/073033
(87) International publication number:
WO 2024/050323 (07.03.2024 Gazette 2024/10)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 30.08.2022 US 202263373909 P

(71) Applicant: Sumitomo Pharma America, Inc.
Marlborough, Massachusetts 01752 (US)

(72) Inventors:
  • DEDIC, Nina
    Marlborough, Massachusetts 01752 (US)
  • HAYES, Robert
    Marlborough, Massachusetts 01752 (US)
  • KENT, Justine
    Marlborough, Massachusetts 01752 (US)

(74) Representative: Vossius & Partner Patentanwälte Rechtsanwälte mbB 
Siebertstrasse 3
81675 München
81675 München (DE)

   


(54) ULOTARONT FOR THE ADJUVANT TREATMENT OF MAJOR DEPRESSIVE DISORDER